Patent · US Active

Methods for sub-typing and treating cancer

US11591658B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

HI-STEM GGMBH · DE

Inventors

Andreas Trumpp · Heidelberg, DE
Simon Raffel · Heidelberg, DE
Mattia Falcone · Heidelberg, DE

Key dates

Filing date	Jan 31, 2018
Grant date	Feb 28, 2023
Priority date	—
Expiry date	Nov 12, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a novel approach for the identification and stratification of subtypes of cancer, particularly subtypes of cancer characterized by an increased expression of BCAT1, particularly Acute Myeloid Leukemia (AML). The invention furthermore relates to a novel approach with respect to the treatment of cancer, particularly subtypes of cancer characterized by an increased expression of BCAT1, particularly Acute Myeloid Leukemia (AML).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.